Company Filing History:
Years Active: 2019
Title: Zhenwei Shen: Innovator in Vaccine Technology
Introduction
Zhenwei Shen is a notable inventor based in Changchun, China. He has made significant contributions to the field of vaccine technology, particularly in the development of a non-gelatin vaccine protectant composition. His work is crucial in enhancing the efficacy and safety of live attenuated influenza vaccines.
Latest Patents
Zhenwei Shen holds 1 patent for his innovative work. His patent, titled "Non-gelatin vaccine protectant composition and live attenuated influenza vaccine," provides a composition designed to serve as a protectant for live attenuated influenza virus vaccines. The composition includes human serum albumin, sugar, and sodium glutamate in specific concentrations. The patent also outlines a process for preparing the vaccine, which involves dissolving the components in a pH buffer solution, adjusting the pH, performing filtration sterilization, and adding the virus stock.
Career Highlights
Zhenwei Shen is associated with Changchun Bcht Biotechnology Co., where he applies his expertise in biotechnology and vaccine development. His innovative approach to vaccine formulation has the potential to improve public health outcomes by providing safer and more effective vaccination options.
Collaborations
Zhenwei collaborates with talented individuals in his field, including Xiaohui Chen and Fei Xu. Their combined efforts contribute to advancing vaccine technology and addressing global health challenges.
Conclusion
Zhenwei Shen's contributions to vaccine technology exemplify the importance of innovation in public health. His work not only enhances vaccine formulations but also plays a vital role in the ongoing fight against infectious diseases.